Advertisement
Advertisement

EWTX

EWTX logo

Edgewise Therapeutics, Inc. Common Stock

35.32
USD
Sponsored
-0.26
-0.73%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

35.34

+0.02
+0.04%

Edgewise Therapeutics, Inc. Common Stock Profile

About

Edgewise Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing orally bioavailable, small molecule therapies for rare muscle disorders. Edgewise Therapeutics Inc. is based in Boulder, United States.

Info & Links

CEO

Kevin Koch

Headquarters

1715 38TH ST
BOULDER, CO 80301, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.edgewisetx.com

Auditor

KPMG LLP

Share holders

4

Employees

146

Edgewise Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

3.80B

Enterprise Value

3.77B

Enterprise Value/EBITDA(ttm)

-18.46

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.79

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-31.97%

Return on Invested Capital(ttm)

-32.52%

Return on Assets(ttm)

-30.46%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-204.01M

Net Income Available to Common(ttm)

-176.01M

Diluted EPS(ttm)

-1.63

Share Statistics

Beta (5Y Monthly)

0.24

52-Week Change

140.27%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

107.59M

Dividend Yield

0.00%

Float4

82.38M

% Held by Insiders

23.20%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

499.56M

Total Cash Per Share(mrq)

4.64

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

19.85%

Quick Ratio(mrq)

19.85%

Book Value Per Share(mrq)

4.92

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.40

Free Cash Flow(ytd)

-144.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement